 |
pembrolizumab |
|---|---|
| Trade Name | Keytruda |
| Orphan Indication | Multiple myeloma |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-17 00:00:00 |
| Sponsor | Merck, Sharp & Dohme Corp.;One Merck Drive;Whitehouse Station, New Jersey, 08889 |
Related Access Program
AbbVie – Multiple Myeloma
Janssen Research & Development, LLC – Multiple Myeloma
Dana-Farber Cancer Institute – Multiple Myeloma
Bristol-Myers Squibb – Multiple Myeloma
Peking University – Multiple Myeloma
Novartis Pharmaceuticals – Multiple Myeloma
Onyx Pharmaceuticals, Inc., an Amgen subsidiary – Multiple myeloma